secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apellis Pharmaceuticals, Inc. (APLS)
CIK:        0001492422
Form:       8-K
Filed at:   2023-06-01T23:59:59+00:00
Accession:  0001193125-23-158943
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Apellis stockholders re-elect Gerald Chan and Cedric Francois as Class III directors
--------------------------------------------------------------------------------

- Gerald Chan received 82,568,712 votes for and 19,616,976 withheld (5,095,730 broker non-votes).
- Cedric Francois received 101,552,924 votes for and 632,764 withheld (5,095,730 broker non-votes).
- Stockholders ratified Deloitte & Touche as auditor for FY2023 (107,213,813 for, 39,783 against).
- Advisory vote on named executive officer compensation passed with 94,979,579 for, 6,659,652 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492422/000119312523158943/0001193125-23-158943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492422/000119312523158943/d470683d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-158943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer